Are Copay Coupons Actually Making Drugs More Expensive?
(By Charles Ornstein for ProPublica) Consumers, including a ProPublica reporter, love saving money using drug copay coupons. But by upending
Read More
Part D/Prescription Drugs
Medicaid, Private Insurers Begin To Lift Curbs On Pricey Hepatitis C Drugs
(By Judith Graham for Kaiser Health News) After legal battles and lobbying efforts, tens of thousands of people with hepatitis
Read MoreFlorida Doctor Pleads Guilty to Fraud — Years After Complaints About His Prescribing
(By Charles Ornstein for ProPublica) The onetime top prescriber of mental health drugs in Florida’s Medicaid program is awaiting sentencing
Read MoreAnother Insurance Company Paying for Value
Harvard Pilgrim Health Care has reached agreements with Novartis and Eli Lilly to “pay for value” based on patient outcome
Read MoreAre Pharmacy Benefit Managers Working to Lowering Costs
Pharmacy Benefit Managers (PBMs) have begun looking at their huge prescription data in search of economies on behalf of their
Read MoreDoctors Wrestle With Mixed Messages When Deciding Whether To Prescribe Painkillers
(By Shefali Luthra for Kaiser Health News) Steve Diaz, an emergency medicine doctor at Augusta’s MaineGeneral Health, says he knows
Read MoreCalifornia Drug Price Measure Fiercely Opposed By Pharmaceutical Industry
(By Pauline Bartolone for California Healthline) Drugmakers are waging a fierce campaign against a proposed California law that would require
Read MoreFlu-Miffed: Piecing Together Clues On How FluMist Lost Its Place In The Flu-Fighting Toolbox
(By Julie Appleby for Kaiser Health News) What led to the abrupt fall of FluMist — the nasal spray version
Read MorePrice Relief, Innovation, and Competition for Essential Drugs Act will it Lower Drug Costs?
U.S. Representative Janice Schakowsky, (D-IL 9th District), introduced the bill called Price Relief, Innovation, and Competition for Essential Drugs Act
Read MoreThe FDA to Review Diabetes Drugs for Additional Benefits
On June 28th an advisory panel to the U.S. Food and Drug Administration (FDA) will vote on whether a diabetes
Read More